SavedAdd your journal

Journals / Erciyes Medical Journal / 2018 / Cilt: 40 - Sayı: 4

Community-Acquired Pneumonia in Adults: What’s New Focusing on Epidemiology, Microorganisms and Diagnosis?

Sofia TEJADA
Anabel ROMERO
Jordi RELLO
Pages
177–182
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review summarizes on the epidemiology, microbiological etiology, and diagnosis of CAP in adults.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Community-acquired pneumonia (CAP) is one of the most common causes of hospital admissions and death worldwide.
📊
Key Findings & Data:Currently, antimicrobial resistance is increasing, so the accurate diagnosis and determination of the causative microorganism are even more important.
💡
Conclusion & Impact:This review summarizes on the epidemiology, microbiological etiology, and diagnosis of CAP in adults.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Community-acquired pneumonia (CAP) is one of the most common causes of hospital admissions and death worldwide. The incidence and mortality of CAP are associated with the presence of comorbidities and increasing age. Streptococcus pneumoniae is the most frequent causative microorganism of CAP, although in many patients with CAP, the causative microorganism remains unknown. Currently, antimicrobial resistance is increasing, so the accurate diagnosis and determination of the causative microorganism are even more important. This is a key point in reducing both morbidity and mortality from CAP, and appropriate antimicrobial stewardship is now a global priority. This review summarizes on the epidemiology, microbiological etiology, and diagnosis of CAP in adults.

🔖

Cite This Article

TEJADA, S., ROMERO, A., RELLO, J. (2018). Community-Acquired Pneumonia in Adults: What’s New Focusing on Epidemiology, Microorganisms and Diagnosis?. Erciyes Medical Journal, Cilt: 40 - Sayı: 4, 177–182. https://ajindex.com/articles/192520

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Cillóniz C, Rodríguez-Hurtado D, Torres A. Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging. Med Sci 2018; 6(2): 35. [CrossRef] Walden AP, Clarke GM, McKechnie S, Hutton P, Gordon AC, Rello J, et al. Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care 2014; 18(2): 58. [CrossRef] Rello J. Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care 2008; 12(6): 2. [CrossRef] El-Emshaty W, Mashaly M, Moawad A, El-Gamal M, Hewidy A. Diagnostic value of neutrophil lymphocyte ratio versus C-reactive protein in discrimination between different pathogens causing community-acquired pneumonia. Comp Clin Path 2017; 26(4): 757-65. [CrossRef] Leoni D, Rello J. Severe community-acquired pneumonia: optimal management. Curr Opin Pulm Med 2017; 30(2): 240-7. [CrossRef] World Population Prospects: The 2017 Revision | Multimedia Library - United Nations Department of Economic and Social Affairs. Available from: https://www.un.org/development/desa/publications/ world-population-prospects-the-2017-revision.html (accessed on 12 September 2018).
  2. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-Acquired pneumonia requiring hospitalization among U.S. adults. N Eng J Med 2015; 373: 415-27. [CrossRef] Soylar ÖK, Kılınç O, Ellidokuz H. Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society. Turk Thorac J 2015; 16(2): 64-7. [CrossRef] Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis 2017; 36(11): 1999-2006. [CrossRef] Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med 2018; 137: 6-13. [CrossRef] Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2): 27-72. [CrossRef] Tokgoz Akyil FT, Yalcinsoy M, Hazar A, Cilli A, Celenk B, Kilic O, et al. Prognosis of hospitalized patients with community-acquired pneumonia. Pulmonology 2018; 24(3): 164-9. [CrossRef]